海外の治験の状況「1」での検索結果
7748件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Not recruiting
- Efficacy and Safety of FIAsp Compared to Insulin Aspart Both in Combination With Insulin Detemir in Adults With Type 1 Diabetes
- Diabetes;Diabetes Mellitus, Type 1;Diabetes;Diabetes Mellitus, Type 1;Diabetes;Diabetes Mellitus, Type 1
- Belgium, Canada, Czech Republic, Czechia, Finland, Germany, Hungary, Poland, United Kingdom, United States
- 2013-04-11
Not recruiting
- Effectiveness of Paritaprevir/Ritonavir - Ombitasvir, +/- Dasabuvir, +/- Ribavirin in Patients With Chronic Hepatitis C - An Observational Study in Belgium
- Chronic Hepatitis C, Genotype 1 or 4;Chronic Hepatitis C, Genotype 1 or 4;Chronic Hepatitis C, Genotype 1 or 4
- Belgium
- 2015-10-19
Not recruiting
- Efficacy and Safety of Continuous Subcutaneous Insulin Infusion of Faster-acting Insulin Aspart Compared to NovoRapid® in Adults With Type 1 Diabetes
- Diabetes;Diabetes Mellitus, Type 1;Diabetes;Diabetes Mellitus, Type 1;Diabetes;Diabetes Mellitus, Type 1
- Belgium, Canada, France, Germany, Netherlands, Russian Federation, Slovenia, United Kingdom, United States
- 2016-07-04
Not recruiting
- The Efficacy of RAD 001 as Second Line Therapy in Patients With Transitional Cell Carcinoma TCC of the Urothelium
- Urothelial Cancer
- France
- 2013-02-12
Not recruiting
- BEVERLY-C: An Observational Study of Avastin (Bevacizumab) in First-Line Treatment in Elderly Patients With Metastatic Colorectal Cancer
- Colorectal Cancer
- Hungary
- 2013-02-12
Not recruiting
- ARCHER-1050: A Study of Dacomitinib vs. Gefitinib in 1st-Line Treatment Of Advanced NSCLC.
- EGFR Positive Non-small Cell Lung Cancer
- China, Hong Kong, Italy, Japan, Korea, Republic of, Poland, Spain
- 2013-01-21
Not Recruiting
- Iressa RE-challenge in advanced NSCLC EGFR mutated patients who responded to an EGFR-TKI used as first-line or previous treatment - NVALT 16.
- NSCLC Lung cancer EGFR TKI
- The Netherlands
- 2013-01-14
Not Recruiting
- Efficacy, Safety and Tolerability Study of 1 mg Rasagiline in Patients with Amyotrophic Lateral Sclerosis (ALS) Receiving Standard Therapy (Riluzole)
- Amyotrophic Lateral Sclerosis (ALS) br>MedDRA version: 14.1 Level: PT Classification code 10002026 Term: Amyotrophic lateral sclerosis System Organ Class: 10029205 - Nervous system disorders ;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]
- Germany
- 2012-12-21
Not Recruiting
- Phase II trial of oral vinorelbine in a population of patients with lung cancer with an EGFR mutation, after failure to treatment with TKI in first line.
- Patients with: -Histologically or cytologically confirmed NSCLC (stage IIIB or IV) and -epidermal growth factor receptor (EGFR) positive mutation and -previously treated with tyrosine kinase inhibitor (gefitinib or erlotinib) MedDRA version: 14.1 Level: PT Classification code 10029522 Term: Non-small cell lung cancer stage IV System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) MedDRA version: 14.1 Level: PT Classification code 10029521 Term: Non-small cell lung cancer stage IIIB System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) MedDRA version: 14.1 Level: PT Classification code 10029515 Term: Non-small cell lung cancer recurrent System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Diseases [C] - Cancer [C04]
- Argentina, Austria, Poland, Singapore, Taiwan
- 2012-12-03
Not recruiting
- A Study of Lenalidomide Maintenance for High-risk Patients With CLL Following First-line Therapy
- Chronic Lymphocytic Leukemia;Chronic Lymphocytic Leukemia;Chronic Lymphocytic Leukemia
- Germany
- 2012-03-14
Not recruiting
- Pazopanib Hydrochloride or a Placebo in Treating Patients With Non-Small Cell Lung Cancer Who Have Received First-Line Chemotherapy
- Lung Cancer
- Belgium, Egypt, France, Germany, Greece, Netherlands, Slovenia, United Kingdom
- 2010-09-22
Not recruiting
- A Study of GDC-0927 in Postmenopausal Women With Locally Advanced or Metastatic Estrogen Receptor Positive Breast Cancer
- Breast Cancer
- Spain, United States
- 2014-12-04
Not recruiting
- Third Line TKI After 2 TKIs in Patients With mRCC (Tokio Study)
- Renal Cancer Cell;Renal Cancer Cell;Renal Cancer Cell
- Italy
- 2014-11-11
Not Recruiting
- Regorafenib vs placebo as maintenance therapy in no progression patients after first-line platinum and fluoropyrimidines based chemotherapy in HER2 negative locally advanced/metastatic gastric or gastroesophagel junction cancer.
- HER2 negative locally advanced/metastatic gastric or gastroesophagel junction cancer. MedDRA version: 17.1 Level: PT Classification code 10063916 Term: Metastatic gastric cancer System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Diseases [C] - Cancer [C04]
- Italy
- 2014-10-30
Not recruiting
- Cetuximab Rechallenge in Irinotecan-pretreated mCRC, KRAS, NRAS and BRAF Wild-type Treated in 1st Line With Anti-EGFR Therapy (CRICKET).
- Metastatic Colorectal Cancer
- Italy
- 2014-10-15
Not recruiting
- Evaluation of Medical Treatments in MBC Patients According Biological Subtype and Line of Treatments
- Metastatic Breast Cancer
- Italy
- 2014-09-10
Not Recruiting
- This study is designed to assess the efficacy and safety of filanesib + carfilzomib versus single-agent carfilzomib in patients with multiple myeloma who have received at least 2 prior lines of therapy.
- Multiple Myeloma MedDRA version: 17.0 Level: LLT Classification code 10028228 Term: Multiple myeloma System Organ Class: 100000004864 ;Therapeutic area: Diseases [C] - Cancer [C04]
- Austria, Belgium, Canada, Czech Republic, France, Germany, Greece, Hungary, Italy, Netherlands, Poland, Spain, Sweden, United Kingdom, United States
- 2014-09-05
Not recruiting
- Comparative Efficacy and Safety Study of Dolutegravir and Lopinavir/Ritonavir in Second-line Treatment
- Infection, Human Immunodeficiency Virus
- Argentina, Brazil, Chile, China, Colombia, Kenya, Mexico, Peru, Romania, Russian Federation, South Africa, Thailand, Ukraine
- 2014-08-25
Not recruiting
- dMR During First Line Treatment of Non Squamous Lung Cancer: Time Course and Prognostic and Predictive Impact.
- Non-small Cell Lung Cancer
- Sweden
- 2014-07-14
Not recruiting
- Efficacy and Safety of Aflibercept in Combination With FOLFIRI Chemotherapy as 1st Line Treatment for Patients With Metastatic Colorectal Cancer
- Metastatic Colorectal Cancer
- France
- 2014-07-02
